Janus Kinase 3 (JAK3) Peptide
JAK3
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all JAK3 products
- JAK3 (Janus Kinase 3 (JAK3))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- KLLPLDKDYY VVREPGQSPI FWYAPESLSD NIFSRQSDVW SFGVVLYELF
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of JAK3 antibody,
Alternative Names: JAK3 control peptide, JAK3 antibody Blocking Peptide, Anti-JAK3 Blocking Peptide, Janus Kinase 3 Blocking Peptide, JAK-3 Blocking Peptide, JAK3_HUMAN Blocking Peptide, JAKL Blocking Peptide, L-JAK Blocking Peptide, LJAK Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- JAK3 (Janus Kinase 3 (JAK3))
- Synonyms
- JAK-3 Peptide, JAK3_HUMAN Peptide, JAKL Peptide, L-JAK Peptide, LJAK Peptide, fae Peptide, wil Peptide, RATJAK3 Peptide, JAK Peptide, Janus kinase 3 Peptide, JAK3 Peptide, Jak3 Peptide
- Background
- JAK3 is a member of the Janus kinase (JAK) family of tyrosine kinases, which is involved in cytokine receptor-mediated intracellular signal transduction. JAK3 is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in JAK3 are associated with autosomal SCID (severe combined immunodeficiency disease).
- Molecular Weight
- 125 kDa
-
You are here:
